ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,097,000 | +383.2% | 511,391 | +320.9% | 0.00% | – |
| Q4 2021 | $434,000 | -27.2% | 121,501 | -25.8% | 0.00% | – |
| Q3 2021 | $596,000 | -16.3% | 163,754 | +0.3% | 0.00% | – |
| Q2 2021 | $712,000 | -8.2% | 163,343 | -13.6% | 0.00% | – |
| Q1 2021 | $776,000 | -46.4% | 189,040 | -47.9% | 0.00% | – |
| Q4 2020 | $1,448,000 | +233.6% | 362,778 | +125.9% | 0.00% | – |
| Q3 2020 | $434,000 | -47.8% | 160,586 | -46.9% | 0.00% | – |
| Q2 2020 | $831,000 | -49.0% | 302,325 | -56.2% | 0.00% | -100.0% |
| Q1 2020 | $1,629,000 | -26.6% | 690,749 | +46.3% | 0.00% | 0.0% |
| Q4 2019 | $2,220,000 | +296.4% | 472,114 | +182.1% | 0.00% | – |
| Q3 2019 | $560,000 | -36.6% | 167,375 | -37.6% | 0.00% | – |
| Q2 2019 | $883,000 | -12.0% | 268,196 | -19.0% | 0.00% | – |
| Q1 2019 | $1,003,000 | +59.5% | 331,082 | +43.1% | 0.00% | – |
| Q4 2018 | $629,000 | +8.6% | 231,340 | +34.3% | 0.00% | – |
| Q3 2018 | $579,000 | +232.8% | 172,195 | +154.7% | 0.00% | – |
| Q2 2018 | $174,000 | +216.4% | 67,620 | +145.9% | 0.00% | – |
| Q4 2017 | $55,000 | -87.4% | 27,498 | -79.7% | 0.00% | – |
| Q3 2017 | $438,000 | +3.8% | 135,348 | +3.4% | 0.00% | – |
| Q2 2017 | $422,000 | +77.3% | 130,892 | +56.0% | 0.00% | – |
| Q1 2017 | $238,000 | +453.5% | 83,882 | +350.5% | 0.00% | – |
| Q4 2016 | $43,000 | -30.6% | 18,620 | -49.6% | 0.00% | – |
| Q3 2016 | $62,000 | +87.9% | 36,974 | +17.1% | 0.00% | – |
| Q2 2016 | $33,000 | +266.7% | 31,570 | +317.2% | 0.00% | – |
| Q4 2015 | $9,000 | -98.3% | 7,567 | -97.6% | 0.00% | -100.0% |
| Q3 2015 | $542,000 | +4827.3% | 318,653 | +5700.0% | 0.00% | – |
| Q2 2015 | $11,000 | -91.2% | 5,494 | -88.1% | 0.00% | – |
| Q1 2015 | $125,000 | +5.9% | 46,212 | +0.7% | 0.00% | – |
| Q4 2014 | $118,000 | -78.0% | 45,904 | -84.3% | 0.00% | -100.0% |
| Q3 2014 | $537,000 | +25.2% | 293,038 | +82.5% | 0.00% | – |
| Q2 2014 | $429,000 | +187.9% | 160,587 | +277.3% | 0.00% | – |
| Q1 2014 | $149,000 | -62.6% | 42,563 | -52.1% | 0.00% | -100.0% |
| Q4 2013 | $398,000 | +665.4% | 88,841 | +589.5% | 0.00% | – |
| Q3 2013 | $52,000 | -78.3% | 12,884 | -77.6% | 0.00% | – |
| Q2 2013 | $240,000 | – | 57,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|